Modulation of Biodefense Responses to Microbial Pathogens
Modulation of Biodefense Responses to Microbial Pathogens
批准号:
9268551
负责人:
Anthony T Vella
金额:
$266.75万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2019-04-30
关键词:
Acute Lung InjuryAddressAirAlpha CellBacterial ToxinsBiological ModelsCategoriesCellular ImmunityConfocal MicroscopyCoupledDevelopmentEnterotoxinsEnvironmental ExposureEventFlow CytometryFluorescence MicroscopyFood ContaminationGoalsHumanImageImmune responseImmunityImmunologic TechniquesImmunologicsInfectionInfectious AgentInjuryIntestinesListeria monocytogenesLungMediatingMiningModelingMucosal Immune ResponsesMucous MembraneNatural ImmunityOralProcessProteomicsPulmonary PathologyRelapseSalmonella infectionsStaphylococcus aureusSurfaceSystemT cell responseTechnologyTestingToxinViralVirus DiseasesWorkadaptive immune responseadaptive immunitybiodefensecell injurycontaminated waterhuman diseasein vivo Modelinfluenzavirusinnovationinsightmicrobialnovelpathogenprogramsresponsetherapy outcomevaccine development
中文摘要
描述(由申请人提供):该项目“微生物病原体生物防御反应的调节”的更新由四个项目和三个核心组成,重点关注对B类和C类生物防御病原体及其产品的免疫反应。核心假设是,粘膜固有免疫反应和适应性免疫反应激活的早期事件分别决定了是否因感染或细菌毒素暴露而诱导免疫或损伤。每个项目都侧重于主题的一个独特方面,以推进我们对传染性病原体或其毒素的粘膜免疫反应的整体理解。由于人类疾病很容易通过食物、水或空气的故意或意外污染传播,我们的重点是与环境接触界面的粘膜组织。项目1 (Lefrancois)提出研究肠道黏膜T细胞对口腔单核增生李斯特菌(Listeria monocytogenes, LM)感染反应的调控机制。将采用一种模拟人类感染的新系统。项目2 (McSorley)将研究一种复发沙门氏菌感染的新模型,并将确定引发保护性免疫的关键要求。项目3 (Vella)将确定肺部给药金黄色葡萄球菌肠毒素如何介导急性肺损伤。一种创新的蛋白质组学挖掘策略将用于测试新的假设,即T细胞对肠毒素的反应引导细胞损伤过程,表现为深刻的肺部病理。项目4 (Cauley)将研究支持肺部持续细胞免疫抵抗流感病毒感染的机制。该项目利用体内模型、深入的细胞免疫技术和最先进的成像技术,并得到3个核心的支持:行政管理、流式细胞术和荧光显微镜。项目和核心协同作用,相互加强,以实现项目的目标。再加上强有力的机构支持,预计将继续获得对病原体及其副产物的免疫反应调节的重要新见解。
英文摘要
DESCRIPTION (provided by applicant): This renewal of the program project "Modulation of biodefense responses to microbial pathogens" is composed of four projects and three cores focused on the immune response to Category B and C Biodefense Pathogens and their products. The central hypothesis is that early events during activation of the mucosal innate and adaptive immune responses determine whether or not immunity or injury is induced in response to infection, or bacterial toxin exposure, respectively. Each project focuses on a unique aspect of the theme to advance our overall understanding of the mucosal immune response to infectious agents or their toxins. Since human disease can be easily spread by deliberate or accidental contamination of food, water, or air, our focus is on mucosal tissues at the interface with environmental exposure. Project 1 (Lefrancois) proposes to investigate the mechanisms regulating the intestinal mucosal T cell response to oral Listeria monocytogenes infection (LM). A novel system that mimics human infection will be employed. Project 2 (McSorley) will examine a new model of relapsing Salmonella infection and will define the critical requirements to elicit protective immunity. Project 3 (Vella) will determine how pulmonary administration of Staphylococcus aureus enterotoxin mediates acute lung injury. An innovative proteomic mining strategy will be used to test the novel hypothesis that T cell responses against enterotoxins guide a cell damage process that manifests in profound lung pathology. Project 4 (Cauley) will investigate the mechanisms that support sustained cellular immunity in the lungs against influenza virus infection. The projects utilize in vivo models, in-depth cellular immunological techniques and state-of-the-art imaging and are supported by 3 cores: administrative, flow cytometry and fluorescence microscopy. The projects and cores synergistically interact and mutually reinforce one another to achieve the goals of the program. Coupled with strong institutional support, it is anticipated that significant new insights in immune response regulatio to pathogens and their byproducts will continue to be obtained.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fimmu.2017.00171
发表时间:
2017
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Risso GS, Carabajal MV, Bruno LA, Ibañez AE, Coria LM, Pasquevich KA, Lee SJ, McSorley SJ, Briones G, Cassataro J]
通讯作者:
Cassataro J
DOI:
10.1038/s41385-018-0037-0
发表时间:
2018-09
期刊:
Mucosal immunology
影响因子:
8
作者:
[Ménoret A, Buturla JA, Xu MM, Svedova J, Kumar S, Rathinam VAK, Vella AT]
通讯作者:
Vella AT
Salmonella as a model for non-cognate Th1 cell stimulation.
沙门氏菌作为非认知Th1细胞刺激的模型。
DOI:
10.3389/fimmu.2014.00621
发表时间:
2014
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[O'Donnell H, McSorley SJ]
通讯作者:
McSorley SJ
DOI:
10.1016/j.vaccine.2011.01.078
发表时间:
2011-03-24
期刊:
VACCINE
影响因子:
5.5
作者:
[Griffin, Amanda J., McSorley, Stephen J.]
通讯作者:
McSorley, Stephen J.
DOI:
10.4049/jimmunol.1000743
发表时间:
2010-08-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Lee SJ, O'Donnell H, McSorley SJ]
通讯作者:
McSorley SJ
共 26 条
MiR-150 regulated adiose tissue B cells in obesity
-
批准号:10571689
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Anthony T Vella
-
依托单位:
MiR-150 regulated adiose tissue B cells in obesity
-
批准号:10357914
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Anthony T Vella
-
依托单位:
IRAK4 and Systemic Lupus Erythematosus
-
批准号:9920669
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2018
-
负责人:Anthony T Vella
-
依托单位:
IRAK4 and Systemic Lupus Erythematosus
-
批准号:10118270
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2018
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6702215
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:9055615
-
项目类别:
-
资助金额:$266.91万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:7023905
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6614049
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:8661689
-
项目类别:
-
资助金额:$266.08万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:8414902
-
项目类别:
-
资助金额:$252.35万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Impact of Staphylococcus Aureus enterotoxin on pulmonary inflamation
-
批准号:8424005
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6846020
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:7184441
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the mechanism of 4-1BB costimulation
-
批准号:6506130
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2002
-
负责人:Anthony T Vella
-
依托单位:
PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
-
批准号:6541284
-
项目类别:
-
资助金额:$25.85万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
-
批准号:6510813
-
项目类别:
-
资助金额:$27.65万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:7447415
-
项目类别:
-
资助金额:$33.72万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:7256916
-
项目类别:
-
资助金额:$34.37万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
How Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:8918772
-
项目类别:
-
资助金额:$5.78万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
How Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:8628022
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
海外基金